SCHEMBL6421565

SCHEMBL6421565

COC(=O)c1ccc(C(=O)Nc2ccc(C(=O)NN(C(=O)O)C(C)(C)C)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.58
NPC1 O15118 7/20 0.57
RAB9A P51151 7/20 0.57
ATM Q13315 1/20 0.57
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
ALDH1A1 P00352 4/20 0.52
LMNA P02545 2/20 0.52
KDM4E B2RXH2 1/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SMN1; SMN2 Q16637 8/20 0.51
PKM P14618 3/20 0.51
TP53 P04637 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 1/20 0.51
PSMD14 O00487 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6421566 0.84 PTPN1 (0.56) PTPN1NPC1RAB9AATMMEN1
SCHEMBL6421248 0.81 SMN1; SMN2 (0.56) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL8660366 0.81 NPC1 (0.83) PTPN1NPC1RAB9AATMMEN1
SCHEMBL6263820 0.81 NPC1 (0.83) PTPN1NPC1RAB9AATMMEN1
SCHEMBL6416347 0.80 GAA (0.53) RAB9AATMMEN1KMT2AALDH1A1
SCHEMBL4611487 0.78 HDAC3 (0.71) PTPN1NPC1RAB9AATMMEN1
SCHEMBL3882727 0.78 HDAC3 (0.71) PTPN1NPC1RAB9AATMMEN1
SCHEMBL9825973 0.78 POLB (0.80) SMN1; SMN2HPGDHTTPOLB
SCHEMBL9825975 0.78 POLB (0.80) SMN1; SMN2HPGDHTTPOLB
SCHEMBL6421594 0.78 SIRT1 (0.46) ALDH1A1L3MBTL1HPGDHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 2005-02-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) PTPRO, PTPRE, PTPRZ1 PTPN1 16/4885NPC1 1600/4885RAB9A 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.